Service
Phase I-III Process Development
PHARMACEUTICAL
bySymmetry Biosciences, Inc.
United States (US)
ABOUT THE SERVICE
Our team provides robust Phase I-III process development services, supporting the transition of drug candidates through clinical trials.
Information is owner-confirmed
Last updated 0 month ago
Price range